Ovid Therapeutics (OVID) Change in Acquisitions & Divestments (2018 - 2026)

Ovid Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $10.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments changed 0.0% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.0 million (down 61.11% YoY) and the FY2025 annual result came in at $42.0 million, down 67.19% from the prior year.
• Change in Acquisitions & Divestments was $10.0 million for Q1 2026 at Ovid Therapeutics, up from $5.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $60.0 million in Q4 2022 and bottomed at $5.0 million in Q4 2025.
• A 5-year average of $26.0 million and a median of $25.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments surged 280.0% — and 2025, when it tumbled 86.84%.
• Ovid Therapeutics' Change in Acquisitions & Divestments stood at $60.0 million in 2022, then slumped by 83.33% to $10.0 million in 2023, then jumped by 280.0% to $38.0 million in 2024, then tumbled by 86.84% to $5.0 million in 2025, then jumped by 100.0% to $10.0 million in 2026.
• Business Quant data shows OVID's Change in Acquisitions & Divestments at $10.0 million in Q1 2026, $5.0 million in Q4 2025, and $10.0 million in Q3 2025.